Zobrazeno 1 - 10
of 25
pro vyhledávání: '"P M Lacal"'
Autor:
Claudia Ceci, Pedro M. Lacal, Lucio Tentori, Maria Gabriella De Martino, Roberto Miano, Grazia Graziani
Publikováno v:
Nutrients, Vol 10, Iss 11, p 1756 (2018)
Ellagic acid (EA) is a naturally occurring polyphenolic compound endowed with strong antioxidant and anticancer properties that is present in high quantity in a variety of berries, pomegranates, and dried fruits. The antitumor activity of EA has been
Externí odkaz:
https://doaj.org/article/880cb877007f4bb3a2939eb3f397d2c7
Autor:
Grazia eGraziani, Pedro M Lacal
Publikováno v:
Frontiers in Oncology, Vol 5 (2015)
Neuropilin-1 (NRP-1) is a transmembrane glycoprotein that acts as a co-receptor for various members of the VEGF family. Its ability to bind or modulate the activity of a number of other extracellular ligands, such as class 3 semaphorins, TGF-β, HGF,
Externí odkaz:
https://doaj.org/article/e4d4c44f71a9459bad228f85ecad6aaf
Autor:
Ling Luo, Hironori Uehara, Xiaohui Zhang, Subrata K Das, Thomas Olsen, Derick Holt, Jacquelyn M Simonis, Kyle Jackman, Nirbhai Singh, Tadashi R Miya, Wei Huang, Faisal Ahmed, Ana Bastos-Carvalho, Yun Zheng Le, Christina Mamalis, Vince A Chiodo, William W Hauswirth, Judit Baffi, Pedro M Lacal, Angela Orecchia, Napoleone Ferrara, Guangping Gao, Kim Young-hee, Yingbin Fu, Leah Owen, Romulo Albuquerque, Wolfgang Baehr, Kirk Thomas, Dean Y Li, Kakarla V Chalam, Masabumi Shibuya, Salvatore Grisanti, David J Wilson, Jayakrishna Ambati, Balamurali K Ambati
Publikováno v:
eLife, Vol 2 (2013)
Optimal phototransduction requires separation of the avascular photoreceptor layer from the adjacent vascularized inner retina and choroid. Breakdown of peri-photoreceptor vascular demarcation leads to retinal angiomatous proliferation or choroidal n
Externí odkaz:
https://doaj.org/article/fd70fbe1df704e1b9a63339afb2fa5a4
Autor:
Claudia Ceci, Lucio Tentori, Maria Grazia Atzori, Pedro M. Lacal, Elena Bonanno, Manuel Scimeca, Rosella Cicconi, Maurizio Mattei, Maria Gabriella de Martino, Giuseppe Vespasiani, Roberto Miano, Grazia Graziani
Publikováno v:
Nutrients, Vol 8, Iss 11, p 744 (2016)
Ellagic acid (EA) is a polyphenolic compound that can be found as a naturally occurring hydrolysis product of ellagitannins in pomegranates, berries, grapes, green tea and nuts. Previous studies have reported the antitumor properties of EA mainly usi
Externí odkaz:
https://doaj.org/article/4690b59f4c5d40fb95096564eabce5da
Autor:
Emmanuele A. Jannini, Silvia K. Nicolis, Simona Caporali, Valeriana Cesarini, Antonio Costanzo, Federica Todaro, Susanna Dolci, Rebecca Favaro, Pellegrino Rossi, Elisabetta Botti, P M Lacal, Eugenia Guida, V Tassinari, S Di Agostino
Publikováno v:
Oncogene (Basingstoke) 36 (2017): 4508–4515. doi:10.1038/onc.2017.53
info:cnr-pdr/source/autori:Cesarini, V.; Guida, E.; Todaro, F.; Di Agostino, S.; Tassinari, V.; Nicolis, S.; Favaro, R.; Caporali, S.; Lacal, P. M.; Botti, E.; Costanzo, A.; Rossi, P.; Jannini, E. A.; Dolci, S./titolo:Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo/doi:10.1038%2Fonc.2017.53/rivista:Oncogene (Basingstoke)/anno:2017/pagina_da:4508/pagina_a:4515/intervallo_pagine:4508–4515/volume:36
info:cnr-pdr/source/autori:Cesarini, V.; Guida, E.; Todaro, F.; Di Agostino, S.; Tassinari, V.; Nicolis, S.; Favaro, R.; Caporali, S.; Lacal, P. M.; Botti, E.; Costanzo, A.; Rossi, P.; Jannini, E. A.; Dolci, S./titolo:Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo/doi:10.1038%2Fonc.2017.53/rivista:Oncogene (Basingstoke)/anno:2017/pagina_da:4508/pagina_a:4515/intervallo_pagine:4508–4515/volume:36
Melanoma is a dangerous form of skin cancer derived from the malignant transformation of melanocytes. The transcription factor SOX2 is not expressed in melanocytes, however, it has been shown to be differentially expressed between benign nevi and mal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4fc57005c687d939c0f89577236eac6
Progressive Increase in Telomerase Activity From Benign Melanocytic Conditions to Malignant Melanoma
Autor:
Elena Pagani, P. M. Lacal, S. D'Atri, R. S. Taylor, T. Faraggiana, Ruben D. Ramirez, Jerry W. Shay
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 1, Iss 1, Pp 42-49 (1999)
The expression of telomerase activity and the in situ localization of the human telomerase RNA component (hTR) in melanocytic skin lesions was evaluated in specimens from sixty-three patients. Specimens of melanocytic nevi, primary melanomas and subc
Autor:
F, Ruffini, C M, Failla, A, Orecchia, M R, Bani, A S, Dorio, C, Fortes, G, Zambruno, G, Graziani, R, Giavazzi, S, D'Atri, P M, Lacal
Publikováno v:
The British journal of dermatology. 164(5)
Vascular endothelial growth factor (VEGF)-A, placenta growth factor (PlGF) and their corresponding membrane receptors are involved in autocrine and paracrine regulation of melanoma growth and metastasis. Besides the membrane receptors, a soluble form
A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes
Autor:
S Katamine, Toru Miki, J S Gutkind, Daniel C. Link, Keith C. Robbins, P M Lacal, Timothy J. Ley
Publikováno v:
ResearcherID
Scopus-Elsevier
Scopus-Elsevier
The fgr proto-oncogene encodes a nonreceptor protein-tyrosine kinase, designated p55c-fgr. In this study, we have isolated human fgr cDNA molecules from normal monocyte mRNA templates. Nucleotide sequence analysis of the longest fgr cDNA revealed a 5
Publikováno v:
ResearcherID
Recent studies have shown that ligand-activated growth factor receptors as well as transforming versions of nonreceptor protein-tyrosine kinases physically associate with phosphatidylinositol-3 kinase (PI-3 kinase). Reasoning that PI-3 kinase might a
Autor:
S, D'Atri, G, Graziani, P M, Lacal, V, Nisticò, S, Gilberti, I, Faraoni, A J, Watson, E, Bonmassar, G P, Margison
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 294(2)
The DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT) is important in cellular resistance to certain alkylating antitumor agents such as the methylating drug temozolomide (TMZ). To provide a more rational basis for clinical combinati